Multiple myeloma is a type of blood cancer caused by a buildup of abnormal plasma cells in the bone marrow. As the abnormal ...

Single-cell RNA sequencing (scRNA-seq) has confirmed that MM exhibits high intra-tumor heterogeneity, comprising a mixture of ...

Multiple myeloma is a representative blood cancer along with lymphoma and leukemia. Multiple myeloma is the second most common blood cancer after lymphoma in Korea, and it is a more common disease ...

Ajai Chari, MD, argued that more is not always better. More intense treatment regimens, or those with more drugs, don't ...

Drug-Delivering Aptamers Target Leukemia Stem Cells for One-Two Knockout ... New Innovative Local Treatment for Osteolytic Bone Disease in Multiple Myeloma Jan. 14, 2025 — A team of researchers ...

For decades, the diagnosis of multiple myeloma required evidence of end-organ ... and a survivor of pediatric acute lymphoblastic leukemia. A casual "sit and wait" approach is not warranted ...

Therapy-related B-lymphoblastic leukemia (B-ALL) following treatment for multiple myeloma is a rare occurrence. Despite its rarity and the lack of ...

CAR T cells have been highly successful in individuals with B cell leukemia/lymphoma and multiple myeloma (MM). However, most of the CAR T cell targets currently in clinical trials for AML are ...

Researchers have demonstrated the potential of the innovative optical genome mapping (OGM) technique for the diagnosis, ...